EA202090511A1 - Композиция для нормализации уровня липидов в крови - Google Patents

Композиция для нормализации уровня липидов в крови

Info

Publication number
EA202090511A1
EA202090511A1 EA202090511A EA202090511A EA202090511A1 EA 202090511 A1 EA202090511 A1 EA 202090511A1 EA 202090511 A EA202090511 A EA 202090511A EA 202090511 A EA202090511 A EA 202090511A EA 202090511 A1 EA202090511 A1 EA 202090511A1
Authority
EA
Eurasian Patent Office
Prior art keywords
composition
effective amounts
glycyrrhizic acid
blood lipid
lipid levels
Prior art date
Application number
EA202090511A
Other languages
English (en)
Inventor
Артемий Александрович Сергеев
Анна Александровна Никитина
Андрей Владимирович Селезнев
Вера Геннадьевна Щанкина
Екатерина Сергеевна Пряхина
Original Assignee
ДИКОВСКИЙ, Александр Владимирович
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ДИКОВСКИЙ, Александр Владимирович filed Critical ДИКОВСКИЙ, Александр Владимирович
Priority to EA202090511A priority Critical patent/EA202090511A1/ru
Priority to PCT/EA2021/000001 priority patent/WO2021180293A1/en
Publication of EA202090511A1 publication Critical patent/EA202090511A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/24—Cellulose or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Botany (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Microbiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Изобретение относится к композиции, пригодной для нормализации уровня липидов в крови, в том числе липопротеинов низкой плотности, холестерина и триглицеридов, содержащей глицирризиновую кислоту в виде ее фармацевтически приемлемой соли в сочетании с лигнином гидролизным в эффективных количествах, обеспечивающих терапевтически эффективную суточную дозу композиции, а также к биологически активной добавке и продукту для лечебного и профилактического диетического питания. Технический результат заключается в достижении неожиданного синергетического эффекта путем реализации механизма одновременного воздействия на функции печени и кишечника глицирризиновой кислоты в заявленных эффективных количествах в совокупности с выраженной адсорбционной и антиоксидантной активностью гидролизного лигнина в виде лигниноцеллюлозного комплекса в заявленных эффективных количествах.
EA202090511A 2020-03-13 2020-03-13 Композиция для нормализации уровня липидов в крови EA202090511A1 (ru)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EA202090511A EA202090511A1 (ru) 2020-03-13 2020-03-13 Композиция для нормализации уровня липидов в крови
PCT/EA2021/000001 WO2021180293A1 (en) 2020-03-13 2021-03-10 A composition for normalizing blood lipid level

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EA202090511A EA202090511A1 (ru) 2020-03-13 2020-03-13 Композиция для нормализации уровня липидов в крови

Publications (1)

Publication Number Publication Date
EA202090511A1 true EA202090511A1 (ru) 2021-09-30

Family

ID=76011660

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202090511A EA202090511A1 (ru) 2020-03-13 2020-03-13 Композиция для нормализации уровня липидов в крови

Country Status (2)

Country Link
EA (1) EA202090511A1 (ru)
WO (1) WO2021180293A1 (ru)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2308947C1 (ru) 2006-02-26 2007-10-27 Новосибирский институт органической химии им. Н.Н. Ворожцова СО РАН (НИОХ СО РАН) Лекарственное средство с гиполипидемическим эффектом "симваглизин"
RU2396079C1 (ru) 2008-12-03 2010-08-10 Новосибирский институт органической химии им. Н.Н. Ворожцова Сибирского отделения Российской академии наук (НИОХ СО РАН) (статус государственного учреждения) Лекарственное средство с гиполипидемическим эффектом "аторваглизин"
DE102010028365A1 (de) 2010-04-29 2011-11-03 Lichtblick Gmbh Verwendung einer Phospholipid enthaltenden Zusammensetzung zur Entfernung von subkutanen Fettansammlungen
RU2623876C2 (ru) * 2014-11-10 2017-06-29 Александр Владимирович Диковский Фармацевтическая композиция для лечения гиперлипидемии
WO2017210780A1 (en) 2016-06-07 2017-12-14 Fpinnovations Antimicrobial lignin composition derived from wood biomass
RU2683641C2 (ru) 2017-06-07 2019-04-01 Александр Владимирович Диковский Фармацевтическая композиция для лечения гиперлипидимии

Also Published As

Publication number Publication date
WO2021180293A1 (en) 2021-09-16

Similar Documents

Publication Publication Date Title
Wu et al. The antioxidant, immunomodulatory, and anti-inflammatory activities of Spirulina: an overview
US8057825B2 (en) Krill extracts for treatment of cardiovascular diseases
US20120258168A1 (en) Methods and compositions to promote ocular health
KR102665229B1 (ko) 안구 건조 질환 및 마이봄선염의 치료를 위한 조성물
Liu et al. Advances in nutritional supplementation for sarcopenia management
CA2904865A1 (en) Sulforaphane/sulforaphane precursor and phytosterol/phytostanol compositions
Marhuenda et al. Cardiovascular disease and nutrition
Elkomy et al. Anise and grape seed oils as a feed additive to improve the performance, immune response, and antioxidant activity and reduce caecal pathogenic microbes of quail
EA202090511A1 (ru) Композиция для нормализации уровня липидов в крови
US20140186454A1 (en) Dha and epa in the reduction of oxidative stress
US11141397B2 (en) Composition for improving efficacy of L-DOPA treatment
Zhang Role of ω-3 Fatty Acids in Cardiovascular Disease
Du et al. The physiological function of squalene and its application prospects in animal husbandry
AHMAD et al. A comparative study of antioxidant vitamins and simvastatin in hypercholesterolimic rabbits
Zhu et al. A comparative study about the neuroprotective effects of EPA-enriched phosphoethanolamine plasmalogen and phosphatidylethanolamine against oxidative damage in primary hippocampal neurons
US10285967B2 (en) Monoacylglycerols for use in conjunction with a lipase inhibitor and/or diets low in fat and/or calories
CN1255167C (zh) 具有抗氧化的保健营养油
Trinidad et al. Importance of the Nutrition with Antioxidants in the Treatment of Cancer and Others Damages
Badejo et al. Antioxidant Nutraceuticals: Novel Strategies for Combating Chronic Inflammatory Diseases
Alexandrovich et al. Lipoic acid: physiological role and prospects for clinical application.
Badejo et al. Antioxidant Nutraceuticals
Ghiasvand et al. Muscle and oxidative stress
Kumar et al. ANTI-HYPERLIPIDEMIC ACTIVITIES OF MODIFIED DIET IN RATS FED WITH HIGH FAT DIET
CLARK FIGHT INFLAMMATION by INHIBITING NF-kB
Priyadarshani et al. Impact of Moringa oleifera Lam. leaf powder on the altered lipid profile of diabetic mice